Cidara Therapeutics, Inc. (CDTX) financial statements (2021 and earlier)

Company profile

Business Address 6310 NANCY RIDGE DRIVE
SAN DIEGO, CA 92121
State of Incorp. DE
Fiscal Year End December 31
SIC 2836 - Biological Products, Except Diagnostic Substances (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2019
Q4
9/30/2019
Q3
6/30/2019
Q2
3/31/2019
Q1
12/31/2018
Q4
9/30/2018
Q3
6/30/2018
Q2
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments50744557758489
Cash and cash equivalents50744557758489
Restricted cash and investments10      
Receivables      0
Other undisclosed current assets64333817
Total current assets:667748607792106
Noncurrent Assets
Operating lease, right-of-use asset22  
Property, plant and equipment0011111
Other noncurrent assets1211100
Other undisclosed noncurrent assets  22   
Total noncurrent assets:3444211
TOTAL ASSETS:698252647993107
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities10108810810
Accounts payable2322323
Accrued liabilities4444435
Employee-related liabilities4332332
Debt11111010101 
Derivative instruments and hedges, liabilities   1045
Other undisclosed current liabilities101111   
Total current liabilities:30321919201415
Noncurrent Liabilities
Long-term debt and lease obligation11   910
Long-term debt, excluding current maturities     910
Operating lease, liability11  
Liabilities, other than long-term debt    000
Other liabilities    000
Other undisclosed noncurrent liabilities  12   
Total noncurrent liabilities:11120910
Total liabilities:31332020202325
Stockholders' equity
Stockholders' equity attributable to parent38493244597082
Common stock0000000
Additional paid in capital298295281279278276275
Accumulated other comprehensive loss     (0)(0)
Accumulated deficit(260)(246)(249)(235)(219)(206)(193)
Total stockholders' equity:38493244597082
TOTAL LIABILITIES AND EQUITY:698252647993107

Income statement (P&L) ($ in millions)

12/31/2019
Q4
9/30/2019
Q3
6/30/2019
Q2
3/31/2019
Q1
12/31/2018
Q4
9/30/2018
Q3
6/30/2018
Q2
Operating expenses(16)(16)(14)(16)(17)(15)(15)
Other undisclosed operating income219     
Operating income (loss):(14)3(14)(16)(17)(15)(15)
Nonoperating income (expense)001(0)41(1)
Other nonoperating income (expense)  1(0)41(1)
Interest and debt expense(0)  (0)   
Other undisclosed loss from continuing operations before equity method investments, income taxes    (0)  
Net income (loss):(14)3(14)(17)(12)(14)(16)
Other undisclosed net income attributable to parent0  00  
Net income (loss) attributable to parent:(14)3(14)(17)(12)(14)(16)
Preferred stock dividends and other adjustments      (10)
Other undisclosed net loss available to common stockholders, basic (0)     
Net income (loss) available to common stockholders, basic:(14)3(14)(17)(12)(14)(27)
Other undisclosed net income available to common stockholders, diluted 0     
Net income (loss) available to common stockholders, diluted:(14)3(14)(17)(12)(14)(27)

Comprehensive Income ($ in millions)

12/31/2019
Q4
9/30/2019
Q3
6/30/2019
Q2
3/31/2019
Q1
12/31/2018
Q4
9/30/2018
Q3
6/30/2018
Q2
Net income (loss):(14)3(14)(17)(12)(14)(16)
Comprehensive income (loss):(14)3(14)(17)(12)(14)(16)
Other undisclosed comprehensive income, net of tax, attributable to parent0  0000
Comprehensive income (loss), net of tax, attributable to parent:(14)3(14)(17)(12)(14)(16)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: